from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3700c/-

LFCtreatmentdescriptionclass of inhibitor

0.094

Amikacinug/mL Amikacintranslation

-0.100

Cap5-10ug/mL Capreomycintranslation

0.140

Rox10-50 ug/mL Roxithromycintranslation

-0.320

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.220

Rif0.2-5ug/mL Rifampicintranscription

0.210

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.238

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.613

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.068

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.058

Clofazimine10-13 ug/mL Clofaziminerespiration

0.052

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.760

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.143

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.788

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.714

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.123

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.880

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.022

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.457

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.463

Nigericin50 uM Nigericinrespiration

0.263

TRC10-150 ug/mL Triclosanrespiration

-0.647

TRZ10-25 ug/mL Thioridazinerespiration

-1.859

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.033

menadione6-10 ug/mL Menadionerespiration

0.456

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.102

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.597

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.196

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.775

NRP_1Non-replicating persistence stage 1dosRassociated

0.803

Amp0.2mg/mL AmpicillincellWall

-0.305

Cephalexin20-100 ug/mL CephalexincellWall

1.150

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.171

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.455

EMB10-20 ug/mL EthambutolcellWall

-0.041

Eta12-40 ug/mL EthionamidecellWall

-0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.494

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.641

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.723

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.197

BZA0.12 mg/mL BenzamidearomaticAmides

-0.193

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.041

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.126

H2O24 mM hydrogen peroxideDNAdamaging

0.344

Levo10 ug/mL LevofloxacinDNAdamaging

-0.089

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.559

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.282

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.532

UVUV-irradiationDNAdamaging

0.367

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.244

Antimycin12.5-50 ug/mL Antimycin A?

-0.200

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.015

PA_110-50 ug/mL Antitubercular compound PA-1?

0.358

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.749

PA8240.2-2 ug/mL PA-824?

0.129

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.271

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.050

Verapamil50 uM Verapamil?

-0.322

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.740

methoxatin10-20 ug/mL Methoxatin?